If you have a BMI of 25 or higher, type 2 diabetes, or obesity-related conditions, and your provider determines semaglutide is appropriate, a 15-pound weight loss goal is realistic within 1624 weeks
Section 503A permits compounding of drug products as customized therapies for identified individual patients whose medical needs cannot be met by commercially available drug products. 503B compounding , on the other hand, is performed at outsourcing facilities, which are subject to stricter FDA oversight, including cGMP requirements, a requirement to register with FDA, periodic FDA inspections and an obligation to submit adverse event reports and other product-specific information to FDA
Use units = (desired dose in mg / concentration in mg per mL) times 100
The hidden aspect is that the structural losses don't produce symptoms most women would immediately connect to their weight loss - until a fall, a fracture, or a DEXA scan requested for another reason creates the connection retroactively